ReadR


Headline : WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF

Read more from the original article on here at www.prnewswire.com.




Tags : #willow #biosciences #reports #fourth #quarter #fiscal #year #2023 #financials #operations #filing #2023 #aif



No. of Paragraph 18

Completed the reorganization of the Company during 2023 with all lab operations now located in the Sunnyvale, California

Record revenue in 2023 of $1.2 million representing 43% growth over 2022

Record number of new collaborations executed in 2023, with four new partnerships during the year that position Willow for continued growth in 2024

SUNNYVALE, Calif., March 28, 2024 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX:ย WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable ingredients is pleased to announce its financial and operating results for the three months and year ended December 31, 2023, and filing of its Annual Information Form ("AIF"). Selected financial and operational information is outlined below and should be read with Willow's audited consolidated financial statements and management's discussion and analysis as of December 31, 2023, which are available on SEDAR+ at www.sedarplus.ca.

Read more from the original article on here at www.prnewswire.com.


Related Headlines : WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF (in Google.com):

Hello, below you have a "Web" tab to read more content and an "Image" tab to get related pictures

Example : Trends, Country, News, Jobs, Scholarships, Investment, Business, Politics, Adverts, Fashion, Events, Technology and more.